146 related articles for article (PubMed ID: 29729370)
21. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Daly AF; Beckers A
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
[TBL] [Abstract][Full Text] [Related]
22. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
[TBL] [Abstract][Full Text] [Related]
23. Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).
Schernthaner-Reiter MH; Trivellin G; Stratakis CA
Hum Mol Genet; 2018 Aug; 27(15):2604-2613. PubMed ID: 29726992
[TBL] [Abstract][Full Text] [Related]
24. Familial isolated pituitary adenomas: an emerging clinical entity.
Martucci F; Trivellin G; Korbonits M
J Endocrinol Invest; 2012 Dec; 35(11):1003-14. PubMed ID: 23310926
[TBL] [Abstract][Full Text] [Related]
25. AIP mutation identified in a patient with acromegaly caused by pituitary somatotroph adenoma with neuronal choristoma.
Nishizawa H; Fukuoka H; Iguchi G; Inoshita N; Yamada S; Takahashi Y
Exp Clin Endocrinol Diabetes; 2013 May; 121(5):295-9. PubMed ID: 23674160
[TBL] [Abstract][Full Text] [Related]
26. Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.
Hage M; Viengchareun S; Brunet E; Villa C; Pineau D; Bouligand J; Teglas JP; Adam C; Parker F; Lombès M; Tachdjian G; Gaillard S; Chanson P; Tosca L; Kamenický P
J Clin Endocrinol Metab; 2018 May; 103(5):1929-1939. PubMed ID: 29474559
[TBL] [Abstract][Full Text] [Related]
27. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
[TBL] [Abstract][Full Text] [Related]
28. [Aryl hydrocarbon receptor interacting protein gene and familial isolated pituitary adenomas].
Cai F; Zhang YD; Dai CX; Liu XH; Yang YK; Yao Y; Wang RZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):640-4. PubMed ID: 23286415
[TBL] [Abstract][Full Text] [Related]
29. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
[TBL] [Abstract][Full Text] [Related]
30. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS
Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736
[TBL] [Abstract][Full Text] [Related]
31. Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.
Matsumoto R; Izawa M; Fukuoka H; Iguchi G; Odake Y; Yoshida K; Bando H; Suda K; Nishizawa H; Takahashi M; Inoshita N; Yamada S; Ogawa W; Takahashi Y
Endocr J; 2016 Nov; 63(11):953-963. PubMed ID: 27498687
[TBL] [Abstract][Full Text] [Related]
32. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
[TBL] [Abstract][Full Text] [Related]
33. DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.
Ben-Shlomo A; Deng N; Ding E; Yamamoto M; Mamelak A; Chesnokova V; Labadzhyan A; Melmed S
J Clin Invest; 2020 Nov; 130(11):5738-5755. PubMed ID: 32673291
[TBL] [Abstract][Full Text] [Related]
34. Should aip gene screening be recommended in family members of FIPA patients with R16H variant?
Zatelli MC; Torre ML; Rossi R; Ragonese M; Trimarchi F; degli Uberti E; Cannavò S
Pituitary; 2013 Jun; 16(2):238-44. PubMed ID: 22915287
[TBL] [Abstract][Full Text] [Related]
35. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line.
Fukuda T; Tanaka T; Hamaguchi Y; Kawanami T; Nomiyama T; Yanase T
PLoS One; 2016; 11(10):e0164131. PubMed ID: 27706259
[TBL] [Abstract][Full Text] [Related]
36. Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.
Dénes J; Kasuki L; Trivellin G; Colli LM; Takiya CM; Stiles CE; Barry S; de Castro M; Gadelha MR; Korbonits M
PLoS One; 2015; 10(2):e0117107. PubMed ID: 25658813
[TBL] [Abstract][Full Text] [Related]
37. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature.
Gummadavelli A; Dinauer C; McGuone D; Vining EM; Erson-Omay EZ; Omay SB
J Clin Neurosci; 2020 Aug; 78():420-422. PubMed ID: 32336638
[TBL] [Abstract][Full Text] [Related]
38. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
[TBL] [Abstract][Full Text] [Related]
39. Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
Yarman S; Tuncer FN; Serbest E
Pathobiology; 2019; 86(2-3):128-134. PubMed ID: 30630164
[TBL] [Abstract][Full Text] [Related]
40. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
